MilanJAnadkatMD
Dermatology • Saint Louis, MOProfessor, Dermatology Director of Dermatology Clinical Trials, Washington University School of Medicine
Dr. Anadkat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4901 Forest Park Ave
Saint Louis, MO 63108Phone+1 314-362-2643Fax+1 314-747-8693- Is this information wrong?
Summary
- Dr. Milan Anadkat is a dermatologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital and Siteman Cancer Center. He received his medical degree from Northeast Ohio Medical University and has been in practice 16 years. He is experienced in general and complex medical dermatology, chemotherapy related skin toxicity, autoimmune bulls disease, hidradenitis, and graft-versus-host disease.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2004 - 2007- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2001 - 2002
Northeast Ohio Medical UniversityClass of 2001
Certifications & Licensure
MO State Medical License 2002 - 2024- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash Start of enrollment: 2008 Apr 03
- A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis Start of enrollment: 2020 Jun 04
Publications & Presentations
PubMed
- Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.Akimichi Morita, Siew Eng Choon, Hervé Bachelez, Milan J Anadkat, Slaheddine Marrakchi, Min Zheng, Tsen-Fang Tsai, Hamida Turki, Harry Hua, Sushmita Rajeswari, Christi...> ;Dermatology and therapy. 2023 Jan 1
- Factors Associated With Dermatologic Follow-up vs Emergency Department Return in Patients With Hidradenitis Suppurativa After an Initial Emergency Department Visit.Cynthia X Wang, Joanna L Buss, Matthew Keller, Milan J Anadkat> ;JAMA dermatology. 2022 Dec 1
- Consensus on the clinical management of chronic radiation dermatitis and radiation fibrosis: a Delphi survey.Britney N Wilson, Rohan Shah, Christian Menzer, Abdullah Aleisa, Mary D Sun, Bernice Y Kwong, Ben H Kaffenberger, Lucia Seminario-Vidal, Christopher A Barker, Michael ...> ;The British journal of dermatology. 2022 Dec 1
- Join now to see all
Journal Articles
- Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host DiseaseKarl M Saardi, Rachel K Rosenstein, Milan J Anadkat, JAMA Dermatology
Lectures
- Dermatologic Findings in the Stem Cell Transplant PatientAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
- Inflammatory Bowel Disease 2013Washington University School of Medicine, Saint Louis, Missouri - 6/8/2013
- Florida Society of Dermatology & Dermatologic Surgery (FSDDS) 2012 Annual MeetingFlorida Society of Dermatology & Dermatologic Surgery, Orlando, Florida - 5/25/2012
Authored Content
- Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host DiseaseMay 2020
Press Mentions
Study Adds Evidence on the Link Between Leukemia Cutis and Poor Prognosis in AMLMay 6th, 2019
Professional Memberships
- Fellow
Hospital Affiliations
Barnes-Jewish HospitalSaint Louis, Missouri- Siteman Cancer CenterSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
